{"id":42786,"date":"2020-09-16T10:33:19","date_gmt":"2020-09-16T08:33:19","guid":{"rendered":"https:\/\/kymos.com\/news\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\/"},"modified":"2020-09-16T10:33:19","modified_gmt":"2020-09-16T08:33:19","slug":"%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4","status":"publish","type":"post","link":"https:\/\/kymos.com\/zh-hans\/news\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\/","title":{"rendered":"\u751f\u7269\u5236\u836f\u5168\u7403\u5408\u4f5c\u4f19\u4f34"},"content":{"rendered":"

\u8d70\u8fd1 Pablo Cobo\uff1aKymos \u5728\u751f\u7269\u836f\u7269\u5f00\u53d1\u9886\u57df\u7684\u5173\u952e\u610f\u89c1\u9886\u8896<\/strong><\/span><\/h3>\n
\n
\n
\n
\n

\u6211\u4eec\u7684\u751f\u7269\u5236\u836f\u68c0\u6d4b\u8d1f\u8d23\u4eba Pablo Cobo \u662f\u4e00\u4f4d\u5316\u5b66\u4e13\u4e1a\u6bd5\u4e1a\u751f\uff0c\u4e5f\u662f\u751f\u7269\u5236\u5242\u9886\u57df\u7684\u5148\u9a71\u3002\u4ed6\u56de\u5fc6\u8d77\u5728 Ipsen \u7684\u65e9\u671f\u65f6\u5149\uff0c\u5f53\u65f6\u7684\u80bd\u7c7b\u4ea7\u54c1\u5f00\u53d1\u4e0e\u73b0\u5728\u5927\u4e0d\u76f8\u540c\uff1a<\/span><\/p>\n

\u201c\u65e9\u5728 1994 \u5e74\uff0c\u751f\u7269\u5236\u836f\u516c\u53f8\u7684\u5927\u90e8\u5206\u5f00\u53d1\u5de5\u4f5c\u90fd\u662f\u5728\u5185\u90e8\u5b8c\u6210\u7684\uff0c\u4f46\u7531\u4e8e\u4e13\u4e1a\u4eba\u5458\u548c\u4eea\u5668\u7684\u6210\u672c\u9ad8\u6602\uff0c\u4ed6\u4eec\u5f00\u59cb\u5c06\u68c0\u6d4b\u6d3b\u52a8\u5916\u5305\u7ed9\u7b2c\u4e09\u65b9\u7814\u7a76\u673a\u6784\uff0c\u201dCobo \u5148\u751f\u8868\u793a\u3002\u201c\u5982\u4eca\uff0c\u7f3a\u4e4f\u5fc5\u8981\u57fa\u7840\u8bbe\u65bd\u7684\u516c\u53f8\u53ef\u4ee5\u901a\u8fc7\u4e13\u4e1a\u7684 CRO \u548c CDMO\uff0c\u4ee5\u5177\u6709\u6210\u672c\u6548\u76ca\u7684\u65b9\u5f0f\u5f00\u53d1\u7279\u5b9a\u7684\u751f\u7269\u5236\u5242\u548c\u751f\u7269\u7c7b\u4f3c\u836f\u3002\u201d <\/em><\/span><\/p>\n

\u5f53\u524d\u751f\u7269\u5236\u836f\u68c0\u6d4b\u9762\u4e34\u7684\u6311\u6218 <\/strong><\/span><\/p>\n

Kymos \u7684\u751f\u7269\u5236\u836f\u90e8\u95e8\u4e13\u6ce8\u4e8e\u521b\u65b0\u751f\u7269\u5236\u5242\u548c\u751f\u7269\u7c7b\u4f3c\u836f\uff08\u8fd9\u4e24\u4e2a\u4e3b\u8981\u7684\u751f\u7269\u5236\u836f\u7ec6\u5206\u9886\u57df\uff09\u7684\u8d28\u91cf\u63a7\u5236\uff0c\u4f46\u8fd1\u5e74\u6765\u5bf9\u751f\u7269\u7c7b\u4f3c\u836f\u53ef\u6bd4\u6027\u7814\u7a76\u7684\u9700\u6c42\u663e\u8457\u589e\u52a0\u3002Pablo Cobo \u5bf9\u6b64\u6709\u81ea\u5df1\u7684\u770b\u6cd5\uff1a <\/span><\/p>\n

\u201c\u4e0e 80 \u5e74\u4ee3\u4eff\u5236\u836f\u7684\u60c5\u51b5\u7c7b\u4f3c\uff0c\u8bb8\u591a\u91cd\u78c5\u751f\u7269\u5236\u836f\u7684\u4e13\u5229\u5373\u5c06\u5230\u671f\uff0c\u73b0\u5728\u4f5c\u4e3a\u751f\u7269\u7c7b\u4f3c\u836f\u7684\u9700\u6c42\u91cf\u5f88\u5927\u3002\u6211\u4eec\u76ee\u524d\u6b63\u5728\u5904\u7406\u6570\u5341\u79cd\u751f\u7269\u7c7b\u4f3c\u836f\uff0c\u5e76\u63a5\u6536\u6765\u81ea\u5168\u7403\u5ba2\u6237\u7684\u65b9\u6cd5\u8f6c\u79fb\uff1a\u6765\u81ea\u4e9a\u6d32\u7684\u5355\u514b\u9686\u6297\u4f53 (mAbs)\uff1b\u6765\u81ea\u62c9\u7f8e\u7684\u91cd\u7ec4\u6fc0\u7d20\uff1b\u6765\u81ea\u6b27\u6d32\u7684\u751f\u957f\u56e0\u5b50\u2026\u2026\u5904\u7406\u751f\u7269\u7c7b\u4f3c\u836f\u53ca\u5176\u53c2\u7167\u751f\u7269\u5236\u5242\u5177\u6709\u6311\u6218\u6027\uff0c\u56e0\u4e3a\u5b83\u4eec\u65e2\u5177\u6709\u591a\u6837\u6027\uff0c\u53c8\u5177\u6709\u5206\u5b50\u590d\u6742\u6027\uff0c\u800c\u914d\u5907\u6267\u884c\u5176\u8868\u5f81\u6240\u9700\u7684\u6240\u6709\u4e0d\u540c\u5206\u6790\u65b9\u6cd5\u5e76\u4e0d\u603b\u662f\u6700\u6709\u6548\u7684\u9009\u62e9\u3002\u56e0\u6b64\uff0c\u6709\u5174\u8da3\u8fdb\u5165\u751f\u7269\u7c7b\u4f3c\u836f\u5e02\u573a\u7684\u516c\u53f8\u5f80\u5f80\u6bd4\u4ee5\u524d\u7684\u4eff\u5236\u836f\u516c\u53f8\u66f4\u9891\u7e41\u5730\u5916\u5305\u68c0\u6d4b\u670d\u52a1\u3002\u201d <\/em><\/span><\/p>\n

\u8fd9\u79cd\u79ef\u6781\u7684\u8d8b\u52bf\u975e\u5e38\u5f3a\u52b2\uff0c\u5c3d\u7ba1\u53d1\u751f\u4e86\u51a0\u72b6\u75c5\u6bd2\u75ab\u60c5\uff0c\u4f46\u4e0e 2019 \u5e74\u540c\u671f\u76f8\u6bd4\uff0cPablo \u7684\u56e2\u961f\u6240\u7ecf\u5386\u7684\u670d\u52a1\u9700\u6c42\u589e\u957f\u4e86 2.5 \u500d\uff0c\u83b7\u6279\u62a5\u4ef7\u7684\u5e73\u5747\u4ef7\u503c\u589e\u957f\u4e86 44%\u3002<\/span>
\n\u201c\u6211\u4eec\u9884\u89c1\uff0c\u4ece\u4e2d\u957f\u671f\u6765\u770b\uff0c\u751f\u7269\u7c7b\u4f3c\u836f\u5c06\u5360\u636e\u6211\u4eec\u90e8\u95e8\u4e1a\u52a1\u6d3b\u52a8\u7684\u6700\u5927\u4efd\u989d\uff0c\u201d<\/em>Cobo \u5148\u751f\u603b\u7ed3\u9053\u3002<\/span><\/p>\n

Kymos \u7684\u751f\u7269\u5236\u836f\u68c0\u6d4b\u56e2\u961f\u80fd\u63d0\u4f9b\u54ea\u4e9b\u5176\u4ed6 CRO \u65e0\u6cd5\u63d0\u4f9b\u7684\u670d\u52a1\uff1f<\/strong><\/span><\/p>\n

Pablo Cobo \u4e3a\u4ed6\u90a3\u7ecf\u8fc7\u5185\u90e8\u57f9\u8bad\u7684\u4e13\u5bb6\u56e2\u961f\u548c\u8bbe\u65bd\u9f50\u5168\u7684\u5b9e\u9a8c\u5ba4\u611f\u5230\u81ea\u8c6a\uff0c\u4f46\u5ba2\u6237\u9009\u62e9 Kymos \u4f5c\u4e3a\u5176\u53c2\u7167\u5b9e\u9a8c\u5ba4\u8fd8\u6709\u53e6\u4e00\u4e2a\u91cd\u8981\u539f\u56e0\uff1a<\/span><\/p>\n

\u201c\u6211\u4eec\u7684\u8bb8\u591a\u5ba2\u6237\u6765\u81ea\u4e2d\u56fd\u3001\u97e9\u56fd\u3001\u65b0\u52a0\u5761\u3001\u9ece\u5df4\u5ae9\u3001\u5370\u5ea6\u6216\u963f\u6839\u5ef7\u7b49\u56fd\u5bb6\uff0c\u5728\u8fd9\u4e9b\u56fd\u5bb6\u53ef\u4ee5\u627e\u5230\u5176\u4ed6 CRO \u66ff\u4ee3\u65b9\u6848\u548c\u6709\u5229\u4e8e\u5546\u4e1a\u7684\u6cd5\u89c4\uff0c\u201d<\/em>Cobo \u5148\u751f\u5f00\u59cb\u8bf4\u9053\u3002\u201c\u7136\u800c\uff0c\u6240\u6709\u5728\u6b27\u76df\/\u6b27\u6d32\u7ecf\u6d4e\u533a\u4ee5\u5916\u751f\u4ea7\u7684\u836f\u54c1\uff0c\u5305\u62ec\u751f\u7269\u5236\u836f\uff0c\u5728\u4e0a\u5e02\u524d\u5fc5\u987b\u7ecf\u8fc7\u8ba4\u8bc1\u7684\u6b27\u76df\u5b9e\u9a8c\u5ba4\u68c0\u6d4b\u3002\u6211\u4eec\u540c\u65f6\u4e5f\u662f\u8ba4\u8bc1\u7684\u8fdb\u53e3\u5546\u548c\u5236\u9020\u5546\uff0c\u80fd\u591f\u63d0\u4f9b\u8fdb\u53e3\u3001\u6279\u6b21\u68c0\u6d4b\u548c QP \u6279\u6b21\u653e\u884c\u670d\u52a1\uff0c\u8fd9\u4f7f\u5f97\u8fd9\u4e9b\u516c\u53f8\u5c06\u751f\u4ea7\u65b9\u6cd5\u8f6c\u79fb\u5230 Kymos \u53d8\u5f97\u66f4\u52a0\u65b9\u4fbf\uff1a\u6211\u4eec\u53ef\u4ee5\u5728\u6574\u4e2a\u8fc7\u7a0b\u4e2d\u4e3a\u4ed6\u4eec\u63d0\u4f9b\u534f\u52a9\u3002\u201d<\/em> <\/span><\/p>\n

CELLTRION \u5c31\u662f\u8fd9\u6837\u4e00\u5bb6\u5168\u7403\u5ba2\u6237\uff0c\u5b83\u662f\u97e9\u56fd\u9886\u5148\u7684\u516c\u53f8\uff0c\u4e13\u6ce8\u4e8e\u751f\u7269\u7c7b\u4f3c\u836f\u5355\u6297\u548c\u521b\u65b0\u751f\u7269\u5236\u5242\u3002CELLTRION \u5168\u7403 QC \u8fd0\u8425\u56e2\u961f\u7ecf\u7406 Yong Suk Yang \u5206\u4eab\u4e86\u4e0e Kymos \u5408\u4f5c\u7684\u7ecf\u9a8c\uff1a <\/span><\/p>\n

\u201c\u9664\u4e86\u6211\u4eec\u7684\u65d7\u8230\u4ea7\u54c1 Remsima\uff08\u4e00\u79cd\u82f1\u592b\u5229\u6614\u5355\u6297\u751f\u7269\u7c7b\u4f3c\u836f\uff0c\u5728\u7f8e\u56fd\u4ee5 Inflectra \u7684\u540d\u79f0\u9500\u552e\uff09\u4e4b\u5916\uff0c\u6211\u4eec\u76ee\u524d\u6b63\u5728\u5f00\u53d1\u591a\u4e2a\u65b0\u7684\u751f\u7269\u7c7b\u4f3c\u836f\u9879\u76ee\uff0c\u5e76\u8ba4\u4e3a Kymos \u662f\u6b27\u6d32\u6700\u597d\u7684\u836f\u7269\u653e\u884c\u548c\u68c0\u6d4b CRO \u4e4b\u4e00\u3002\u201d <\/em><\/span><\/p>\n

Pablo Cobo \u5bf9 Yang \u5148\u751f\u7684\u8bdd\u8865\u5145\u4e86\u4ed6\u5bf9\u4ee5\u5f80\u9879\u76ee\u7684\u4e2a\u4eba\u770b\u6cd5\uff1a<\/span><\/p>\n

\u201cCELLTRION \u662f\u4e00\u5bb6\u62e5\u6709\u5f3a\u5927\u5206\u6790\u65b9\u6cd5\u5e76\u5bf9\u5176\u4ea7\u54c1\u7ec4\u5408\u6709\u6df1\u523b\u7406\u89e3\u7684\u516c\u53f8\u3002\u4e3a\u4ed6\u4eec\u5de5\u4f5c\u662f\u771f\u6b63\u7684\u8363\u5e78\uff0c\u56e0\u4e3a\u8fd9\u7ed9\u4e86\u6211\u4eec\u5b9e\u65bd\u9ad8\u6027\u80fd\u5355\u6297\u8868\u5f81\u6280\u672f\uff08\u5982\u6bdb\u7ec6\u7ba1\u7535\u6cf3\u6216 Protein Simple \u56fe\u50cf\u7b49\u7535\u805a\u7126 (iCE3)\uff09\u7684\u673a\u4f1a\u3002\u201d<\/em>Cobo \u5148\u751f\u7ee7\u7eed\u8bf4\u9053\uff1a\u201c\u6211\u5c06\u6211\u4eec\u5ba2\u6237\u7684\u9879\u76ee\u89c6\u4e3a\u4e00\u79cd\u53cc\u5411\u7684\u5408\u4f5c\u4f19\u4f34\u5173\u7cfb\uff1a\u6211\u4eec\u534f\u52a9\u4ed6\u4eec\u6ee1\u8db3\u6240\u6709\u7684 QC \u9700\u6c42\uff0c\u5e76\u5728\u8fc7\u7a0b\u4e2d\u83b7\u5f97\u5b9d\u8d35\u7684\u8bc0\u7a8d\u3002\u7ecf\u8fc7\u591a\u5e74\u5bf9\u521b\u65b0\u751f\u7269\u5236\u5242\u548c\u751f\u7269\u7c7b\u4f3c\u836f\u7684\u68c0\u6d4b\uff0c\u6211\u4eec\u7684\u7ecf\u9a8c\u4e0d\u8a00\u800c\u55bb\u3002\u201d<\/em><\/span><\/p>\n

\u672a\u6765\u5c55\u671b<\/strong><\/span>
\n2012 \u5e74\uff0cKymos \u7684\u751f\u7269\u5236\u836f\u68c0\u6d4b\u90e8\u95e8\u4ec5\u7531\u4e24\u540d\u6210\u5458\u7ec4\u6210\u3002\u4eca\u5929\uff0c\u7ecf\u8fc7\u4e00\u6b21\u642c\u8fc1\u548c\u4e24\u6b21\u5b9e\u9a8c\u5ba4\u6269\u5efa\uff0cPablo \u7684\u56e2\u961f\u5df2\u7ecf\u589e\u957f\u4e86\u8fd1\u5341\u500d\uff0c\u5e76\u4e14\u5728\u5f53\u524d\u5916\u5305\u8d8b\u52bf\u7684\u63a8\u52a8\u4e0b\uff0c\u4eab\u6709\u4e50\u89c2\u7684\u589e\u957f\u9884\u6d4b\u3002\u4ed6\u4eec\u4e00\u8d2f\u4e14\u53ef\u9760\u7684\u5de5\u4f5c\u8d62\u5f97\u4e86\u5168\u7403\u5ba2\u6237\u7684\u79ef\u6781\u53cd\u9988\uff0c\u5e76\u4f7f Kymos \u8dfb\u8eab \u5168\u7403 10 \u5f3a\u751f\u7269\u7c7b\u4f3c\u836f\u670d\u52a1\u63d0\u4f9b\u5546<\/a><\/strong>\u3002\u90a3\u4e48\uff0c\u62e5\u6709\u5982\u6b64\u4ee4\u4eba\u7fa1\u6155\u7684\u5730\u4f4d\uff0cPablo Cobo \u8fd8\u6709\u4ec0\u4e48\u5962\u6c42\u5462\uff1f\u4ed6\u7684\u56de\u7b54\u5f88\u76f4\u63a5\uff1a <\/span><\/p>\n

\u201c\u4e00\u4e2a\u65b0\u5b9e\u9a8c\u5ba4\uff01\u6211\u4eec\u53bb\u5e74\u521a\u521a\u6269\u5927\u4e86\u8bbe\u65bd\uff0c\u4f46\u7a7a\u95f4\u5df2\u7ecf\u4e0d\u591f\u7528\u4e86\uff01\u201d<\/em><\/span><\/p>\n

 <\/p>\n

\u5728\u8fd9\u91cc\uff0c\u60a8\u53ef\u4ee5\u67e5\u770b\u6709\u5173 Kymos \u751f\u7269\u7c7b\u4f3c\u836f\u68c0\u6d4b<\/strong><\/a>\u3001\u751f\u7269\u5236\u5242\u548c\u751f\u7269\u7c7b\u4f3c\u836f\u8868\u5f81<\/a><\/strong> \u4ee5\u53ca \u751f\u7269\u5236\u5242\u548c\u751f\u7269\u7c7b\u4f3c\u836f\u751f\u7269\u5206\u6790<\/strong><\/a> \u7684\u66f4\u591a\u4fe1\u606f\uff0c\u6216\u901a\u8fc7 commercial<\/a>@kymos.com<\/a> \u8054\u7cfb\u6211\u4eec\u3002<\/span><\/p>\n

CELLTRION \u662f\u97e9\u56fd\u5236\u836f\u884c\u4e1a\u7684\u9886\u5148\u529b\u91cf\u3002\u4ed6\u4eec\u4ece\u4e00\u4e2a\u5236\u836f\u884c\u4e1a\u76f8\u5bf9\u843d\u540e\u7684\u56fd\u5bb6\u63a8\u51fa\u4e86\u4e16\u754c\u4e0a\u7b2c\u4e00\u4e2a\u201c\u6297\u4f53\u751f\u7269\u7c7b\u4f3c\u836f\u201d\uff0c\u5e76\u8ba1\u5212\u6210\u957f\u4e3a\u4e00\u5bb6\u5168\u7403\u751f\u7269\u5236\u836f\u516c\u53f8\uff0c\u5728\u5c0f\u5206\u5b50\u836f\u7269\u548c\u6cdb\u5728\u533b\u7597\u5e73\u53f0\u4e1a\u52a1\u7b49\u65b0\u4e1a\u52a1\u9886\u57df\u91c7\u7528\u72ec\u7279\u7684\u65b9\u6cd5\u3002\u6709\u5173 CELLTRION \u7684\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u901a\u8fc7 contact@celltrion.com<\/a> \u4e0e\u5176\u8054\u7cfb\u3002 <\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

\u8d70\u8fd1 Pablo C […]<\/p>\n","protected":false},"author":6,"featured_media":42787,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[382],"tags":[],"class_list":["post-42786","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-kymos-"],"acf":[],"yoast_head":"\n\u751f\u7269\u5236\u836f\u5168\u7403\u5408\u4f5c\u4f19\u4f34 | Kymos<\/title>\n<meta name=\"description\" content=\"\u751f\u7269\u5236\u836f\u68c0\u6d4b\u8d1f\u8d23\u4eba Pablo Cobo \u4e0e CELLTRION \u5206\u4eab\u4ed6\u4eec\u5bf9\u751f\u7269\u5236\u836f\u5e02\u573a\u7684\u89c1\u89e3\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kymos.com\/zh-hans\/news\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u751f\u7269\u5236\u836f\u5168\u7403\u5408\u4f5c\u4f19\u4f34 | Kymos\" \/>\n<meta property=\"og:description\" content=\"\u751f\u7269\u5236\u836f\u68c0\u6d4b\u8d1f\u8d23\u4eba Pablo Cobo \u4e0e CELLTRION \u5206\u4eab\u4ed6\u4eec\u5bf9\u751f\u7269\u5236\u836f\u5e02\u573a\u7684\u89c1\u89e3\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kymos.com\/zh-hans\/news\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\/\" \/>\n<meta property=\"og:site_name\" content=\"Kymos\" \/>\n<meta property=\"article:published_time\" content=\"2020-09-16T08:33:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kymos.com\/wp-content\/uploads\/2021\/11\/Biopharmaceutical-Global-Partners_srt-e1658232466300.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"437\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Joan Puig de Dou\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@KymosGroup\" \/>\n<meta name=\"twitter:site\" content=\"@KymosGroup\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Joan Puig de Dou\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/kymos.com\\\/zh-hans\\\/news\\\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/zh-hans\\\/news\\\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\\\/\"},\"author\":{\"name\":\"Joan Puig de Dou\",\"@id\":\"https:\\\/\\\/kymos.com\\\/zh-hans\\\/#\\\/schema\\\/person\\\/264c93ce9dcf43caa9d634aeafab965c\"},\"headline\":\"\u751f\u7269\u5236\u836f\u5168\u7403\u5408\u4f5c\u4f19\u4f34\",\"datePublished\":\"2020-09-16T08:33:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/zh-hans\\\/news\\\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\\\/\"},\"wordCount\":59,\"image\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/zh-hans\\\/news\\\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/Biopharmaceutical-Global-Partners_srt-e1658232466300.png\",\"articleSection\":[\"Kymos \u96c6\u56e2\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/kymos.com\\\/zh-hans\\\/news\\\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\\\/\",\"url\":\"https:\\\/\\\/kymos.com\\\/zh-hans\\\/news\\\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\\\/\",\"name\":\"\u751f\u7269\u5236\u836f\u5168\u7403\u5408\u4f5c\u4f19\u4f34 | Kymos\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/zh-hans\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/zh-hans\\\/news\\\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/zh-hans\\\/news\\\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/Biopharmaceutical-Global-Partners_srt-e1658232466300.png\",\"datePublished\":\"2020-09-16T08:33:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/zh-hans\\\/#\\\/schema\\\/person\\\/264c93ce9dcf43caa9d634aeafab965c\"},\"description\":\"\u751f\u7269\u5236\u836f\u68c0\u6d4b\u8d1f\u8d23\u4eba Pablo Cobo \u4e0e CELLTRION \u5206\u4eab\u4ed6\u4eec\u5bf9\u751f\u7269\u5236\u836f\u5e02\u573a\u7684\u89c1\u89e3\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/zh-hans\\\/news\\\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\\\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/kymos.com\\\/zh-hans\\\/news\\\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/kymos.com\\\/zh-hans\\\/news\\\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\\\/#primaryimage\",\"url\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/Biopharmaceutical-Global-Partners_srt-e1658232466300.png\",\"contentUrl\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/Biopharmaceutical-Global-Partners_srt-e1658232466300.png\",\"width\":800,\"height\":437,\"caption\":\"Biopharmaceutical Global Partners\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/kymos.com\\\/zh-hans\\\/news\\\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/kymos.com\\\/zh-hans\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u751f\u7269\u5236\u836f\u5168\u7403\u5408\u4f5c\u4f19\u4f34\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/kymos.com\\\/zh-hans\\\/#website\",\"url\":\"https:\\\/\\\/kymos.com\\\/zh-hans\\\/\",\"name\":\"Kymos Group\",\"description\":\"Kymos Group\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/kymos.com\\\/zh-hans\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/kymos.com\\\/zh-hans\\\/#\\\/schema\\\/person\\\/264c93ce9dcf43caa9d634aeafab965c\",\"name\":\"Joan Puig de Dou\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g\",\"caption\":\"Joan Puig de Dou\"},\"description\":\"Active in the pharmaceutical marketing for over 30 years President of CataloniaBIO&HealthTech CEO and Qualified Person at Kymos Leader of Kymos team, guaranteeing a trustable, ethical and scientific correct editorial publications. Experience Joan Puig de Dou started his career at Laboratorios Menarini first as scientist later as Qualified Person and finally as Operations General Manager. 2010 he entered Kymos where he became CEO in 2015. 2022 Joan Puig de Dou was elected as president of CataloniaBio&HealthTech to represent the Catalonian biotech industry nationally and internationally. Expertise Joan Puig de Dou has extensive experience in writing scientific content adopting a didactic approach that fits any reader\u2019s level of expertise. He publishes regularely on Kymos\u2019 webpage, social media and in the specialized press. Education He graduated from Universitat de Barcelona as Pharmacist and from IESE Business School\u2019s Programa Diecci\u00f3n General (PDG) Want to know him better? Read his interview in PharmaBoardrooom in January 2019 and more about his presidency of CataloniaBio at Parc Sc\u00edentific de Barcelona.\",\"url\":\"https:\\\/\\\/kymos.com\\\/zh-hans\\\/news\\\/author\\\/joan-puig-de-dou\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u751f\u7269\u5236\u836f\u5168\u7403\u5408\u4f5c\u4f19\u4f34 | Kymos","description":"\u751f\u7269\u5236\u836f\u68c0\u6d4b\u8d1f\u8d23\u4eba Pablo Cobo \u4e0e CELLTRION \u5206\u4eab\u4ed6\u4eec\u5bf9\u751f\u7269\u5236\u836f\u5e02\u573a\u7684\u89c1\u89e3","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kymos.com\/zh-hans\/news\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\/","og_locale":"zh_CN","og_type":"article","og_title":"\u751f\u7269\u5236\u836f\u5168\u7403\u5408\u4f5c\u4f19\u4f34 | Kymos","og_description":"\u751f\u7269\u5236\u836f\u68c0\u6d4b\u8d1f\u8d23\u4eba Pablo Cobo \u4e0e CELLTRION \u5206\u4eab\u4ed6\u4eec\u5bf9\u751f\u7269\u5236\u836f\u5e02\u573a\u7684\u89c1\u89e3","og_url":"https:\/\/kymos.com\/zh-hans\/news\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\/","og_site_name":"Kymos","article_published_time":"2020-09-16T08:33:19+00:00","og_image":[{"width":800,"height":437,"url":"https:\/\/kymos.com\/wp-content\/uploads\/2021\/11\/Biopharmaceutical-Global-Partners_srt-e1658232466300.png","type":"image\/png"}],"author":"Joan Puig de Dou","twitter_card":"summary_large_image","twitter_creator":"@KymosGroup","twitter_site":"@KymosGroup","twitter_misc":{"\u4f5c\u8005":"Joan Puig de Dou"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/kymos.com\/zh-hans\/news\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\/#article","isPartOf":{"@id":"https:\/\/kymos.com\/zh-hans\/news\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\/"},"author":{"name":"Joan Puig de Dou","@id":"https:\/\/kymos.com\/zh-hans\/#\/schema\/person\/264c93ce9dcf43caa9d634aeafab965c"},"headline":"\u751f\u7269\u5236\u836f\u5168\u7403\u5408\u4f5c\u4f19\u4f34","datePublished":"2020-09-16T08:33:19+00:00","mainEntityOfPage":{"@id":"https:\/\/kymos.com\/zh-hans\/news\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\/"},"wordCount":59,"image":{"@id":"https:\/\/kymos.com\/zh-hans\/news\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\/#primaryimage"},"thumbnailUrl":"https:\/\/kymos.com\/wp-content\/uploads\/2021\/11\/Biopharmaceutical-Global-Partners_srt-e1658232466300.png","articleSection":["Kymos \u96c6\u56e2"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/kymos.com\/zh-hans\/news\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\/","url":"https:\/\/kymos.com\/zh-hans\/news\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\/","name":"\u751f\u7269\u5236\u836f\u5168\u7403\u5408\u4f5c\u4f19\u4f34 | Kymos","isPartOf":{"@id":"https:\/\/kymos.com\/zh-hans\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kymos.com\/zh-hans\/news\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\/#primaryimage"},"image":{"@id":"https:\/\/kymos.com\/zh-hans\/news\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\/#primaryimage"},"thumbnailUrl":"https:\/\/kymos.com\/wp-content\/uploads\/2021\/11\/Biopharmaceutical-Global-Partners_srt-e1658232466300.png","datePublished":"2020-09-16T08:33:19+00:00","author":{"@id":"https:\/\/kymos.com\/zh-hans\/#\/schema\/person\/264c93ce9dcf43caa9d634aeafab965c"},"description":"\u751f\u7269\u5236\u836f\u68c0\u6d4b\u8d1f\u8d23\u4eba Pablo Cobo \u4e0e CELLTRION \u5206\u4eab\u4ed6\u4eec\u5bf9\u751f\u7269\u5236\u836f\u5e02\u573a\u7684\u89c1\u89e3","breadcrumb":{"@id":"https:\/\/kymos.com\/zh-hans\/news\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kymos.com\/zh-hans\/news\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/kymos.com\/zh-hans\/news\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\/#primaryimage","url":"https:\/\/kymos.com\/wp-content\/uploads\/2021\/11\/Biopharmaceutical-Global-Partners_srt-e1658232466300.png","contentUrl":"https:\/\/kymos.com\/wp-content\/uploads\/2021\/11\/Biopharmaceutical-Global-Partners_srt-e1658232466300.png","width":800,"height":437,"caption":"Biopharmaceutical Global Partners"},{"@type":"BreadcrumbList","@id":"https:\/\/kymos.com\/zh-hans\/news\/%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%a8%e7%90%83%e5%90%88%e4%bd%9c%e4%bc%99%e4%bc%b4\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kymos.com\/zh-hans\/"},{"@type":"ListItem","position":2,"name":"\u751f\u7269\u5236\u836f\u5168\u7403\u5408\u4f5c\u4f19\u4f34"}]},{"@type":"WebSite","@id":"https:\/\/kymos.com\/zh-hans\/#website","url":"https:\/\/kymos.com\/zh-hans\/","name":"Kymos Group","description":"Kymos Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kymos.com\/zh-hans\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Person","@id":"https:\/\/kymos.com\/zh-hans\/#\/schema\/person\/264c93ce9dcf43caa9d634aeafab965c","name":"Joan Puig de Dou","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/secure.gravatar.com\/avatar\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g","caption":"Joan Puig de Dou"},"description":"Active in the pharmaceutical marketing for over 30 years President of CataloniaBIO&HealthTech CEO and Qualified Person at Kymos Leader of Kymos team, guaranteeing a trustable, ethical and scientific correct editorial publications. Experience Joan Puig de Dou started his career at Laboratorios Menarini first as scientist later as Qualified Person and finally as Operations General Manager. 2010 he entered Kymos where he became CEO in 2015. 2022 Joan Puig de Dou was elected as president of CataloniaBio&HealthTech to represent the Catalonian biotech industry nationally and internationally. Expertise Joan Puig de Dou has extensive experience in writing scientific content adopting a didactic approach that fits any reader\u2019s level of expertise. He publishes regularely on Kymos\u2019 webpage, social media and in the specialized press. Education He graduated from Universitat de Barcelona as Pharmacist and from IESE Business School\u2019s Programa Diecci\u00f3n General (PDG) Want to know him better? Read his interview in PharmaBoardrooom in January 2019 and more about his presidency of CataloniaBio at Parc Sc\u00edentific de Barcelona.","url":"https:\/\/kymos.com\/zh-hans\/news\/author\/joan-puig-de-dou\/"}]}},"_links":{"self":[{"href":"https:\/\/kymos.com\/zh-hans\/wp-json\/wp\/v2\/posts\/42786","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kymos.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kymos.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kymos.com\/zh-hans\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/kymos.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=42786"}],"version-history":[{"count":0,"href":"https:\/\/kymos.com\/zh-hans\/wp-json\/wp\/v2\/posts\/42786\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kymos.com\/zh-hans\/wp-json\/wp\/v2\/media\/42787"}],"wp:attachment":[{"href":"https:\/\/kymos.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=42786"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kymos.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=42786"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kymos.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=42786"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}